Biotech's First IPO of 2024 Soared. Good Times Could Be Ahead for the Stocks.
Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might...
Source: marketwatch.com